We are live on !
Find out more
Marex Group Portfolio holdings
AUM
$23.6B
Turnover
47.63%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter Est. Return
+50.25%
1 Year Est. Return
+57.16%
3 Year Est. Return
+254.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$23.6B
AUM Growth
+$7.75B
(+49%)
Cap. Flow
+$1.27B
Cap. Flow % of AUM
Cap. Flow %
5.38%
Top 10 Holdings %
Top 10 Hldgs %
32.82%
Holding
1,394
New
387
Increased
323
Reduced
330
Closed
277
Avg Time Held
Equity + Options
0.7
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.3
years
Avg Time Held Equity only
0.8
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Optoelectronics
AAOI
|
+$413M |
| 2 |
ServiceNow
NOW
|
+$374M |
| 3 |
SpaceX
SPCX
|
+$368M |
| 4 |
AXT Inc
AXTI
|
+$320M |
| 5 |
AST SpaceMobile
ASTS
|
+$312M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$364M |
| 2 |
Lumentum
LITE
|
+$290M |
| 3 |
Strategy Inc
MSTR
|
+$282M |
| 4 |
Mastercard
MA
|
+$211M |
| 5 |
Booking.com
BKNG
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.34% |
| 2 | Technology | 28.9% |
| 3 | Industrials | 5.15% |
| 4 | Financials | 4.71% |
| 5 | Healthcare | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1026
Prairie Operating Co
PROP
$40.1M
| $180K | ﹤0.01% |
+250,164
| New | +$270K |
2026 Q2
0 quarters
|
|
1027
VivoPower PLC
VIVO
$70.4M
| $175K | ﹤0.01% |
33,754
-6,000
| -15% | -$24.8K |
2025 Q3
3 quarters
|
|
1028
Tenaya Therapeutics
TNYA
$91.9M
| $174K | ﹤0.01% |
235,500
| – | – |
2024 Q4
6 quarters
|
|
1029
Morgan Stanley Emerging Markets Debt Fund
MSD
$136M
| $173K | ﹤0.01% |
+23,751
| New | +$174K |
2026 Q2
0 quarters
|
|
1030
FMC
FMC
$826M
| $170K | ﹤0.01% |
14,803
+4,050
| +38% | +$56.5K |
2026 Q1
1 quarter
|
|
1031
Eightco Holdings
ORBS
$341M
| $167K | ﹤0.01% |
240,000
+229,700
| +2,230% | +$207K |
2026 Q1
1 quarter
|
|
1032
OMS Energy Technologies
OMSE
$171M
| $164K | ﹤0.01% |
42,552
| – | – |
2025 Q4
2 quarters
|
|
1033
Cohen & Steers Quality Income Realty Fund
RQI
$1.52B
| $160K | ﹤0.01% |
+13,000
| New | +$169K |
2026 Q2
0 quarters
|
|
1034
Guggenheim Strategic Opportunities Fund
GOF
$1.9B
| $159K | ﹤0.01% |
+14,580
| New | +$163K |
2026 Q2
0 quarters
|
|
1035
Saba Capital Income & Opportunities Fund
BRW
$297M
| $158K | ﹤0.01% |
24,000
-6,000
| -20% | -$40.4K |
2026 Q1
1 quarter
|
|
1036
Teladoc Health
TDOC
$1.13B
| $158K | ﹤0.01% |
18,590
-38,724
| -68% | -$258K |
2022 Q4
14 quarters
|
|
1037
Conagra Brands
CAG
$6.89B
| $157K | ﹤0.01% |
+11,676
| New | +$163K |
2026 Q2
0 quarters
|
|
1038
BTQ Technologies Corp
BTQ
$329M
| $154K | ﹤0.01% |
+28,537
| New | +$106K |
2026 Q2
0 quarters
|
|
1039
Defi Technologies
DEFT
$164M
| $152K | ﹤0.01% |
296,200
| – | – |
2025 Q3
3 quarters
|
|
1040
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$3.32B
| $151K | ﹤0.01% |
+4,674
| New | +$557K |
2026 Q2
0 quarters
|
|
1041
Lakewood-Amedex Biotherapeutics
LABT
$1.37M
| $151K | ﹤0.01% |
+48,167
| New | +$826K |
2026 Q2
0 quarters
|
|
1042
Biomea Fusion
BMEA
$53.3M
| $147K | ﹤0.01% |
100,000
| – | – |
2024 Q2
8 quarters
|
|
1043
5E Advanced Materials
FEAM
$107M
| $146K | ﹤0.01% |
104,950
+19,138
| +22% | +$31.9K |
2023 Q4
10 quarters
|
|
1044
Diamondrock Hospitality Co
DRH
$2.82B
| $144K | ﹤0.01% |
+11,841
| New | +$129K |
2026 Q2
0 quarters
|
|
1045
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.69B
| $136K | ﹤0.01% |
+14,173
| New | +$130K |
2026 Q2
0 quarters
|
|
1046
Protara Therapeutics
TARA
$151M
| $135K | ﹤0.01% |
35,250
-20,000
| -36% | -$95.1K |
2025 Q3
3 quarters
|
|
1047
Voyager Therapeutics
VYGR
$135M
| $134K | ﹤0.01% |
38,322
| – | – |
2024 Q4
6 quarters
|
|
1048
TAL Education Group
TAL
$6.42B
| $131K | ﹤0.01% |
+13,684
| New | +$144K |
2026 Q2
0 quarters
|
|
1049
FS Specialty Lending Fund
FSSL
$884M
| $130K | ﹤0.01% |
+11,654
| New | +$138K |
2026 Q2
0 quarters
|
|
1050
Nuveen Municipal Credit Income Fund
NZF
$2.16B
| $130K | ﹤0.01% |
+10,216
| New | +$128K |
2026 Q2
0 quarters
|
|
Similar funds
Marex Group's Q2 2026 Portfolio in Review
As of Q2 2026, Marex Group held 1,394 positions worth $23.6B, up 49% from $15.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marex Group deployed $1.27B of net new capital in Q2 2026, opening 387 new positions and adding to 323 existing holdings. Its largest new stake was SpaceX: 2,163,897 shares worth $370M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, up from 48% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Sandisk, an estimated $364M trimmed.
- Marex Group's largest Q2 2026 buy was SpaceX: 2,163,897 shares worth $370M.
- Marex Group added most to Applied Optoelectronics in Q2 2026, an estimated $413M increase.
- Marex Group's biggest Q2 2026 reduction was Sandisk, cutting an estimated $364M.
- Marex Group fully exited Blackrock in Q2 2026, selling an estimated $77.5M.
- Marex Group's ten largest holdings make up 33% of its $23.6B portfolio in Q2 2026.
- Marex Group opened 387 new positions and closed 277 in Q2 2026.
- Marex Group's portfolio value rose 49% quarter-over-quarter to $23.6B.
Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.